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Macrophages are essential phagocytic cells involved in both innate and 
adaptive immune systems and play vital roles in the host defense and inflammation. 
Macrophages have a remarkably high capacity to clear unnecessary cellular materials 
in interstitial environment through a process called “phagocytosis”, which is affected 
by many factors including suppressors of cytokine signaling (SOCS). SOCSs are a 
group of intracellular proteins that downregulate the cytokine signals involved in 
various JAK/STAT pathways through a negative feedback loop. This study focuses on 
investigating the effects of SOCS1 and SOCS3 on the phagocytic ability of RAW 
264.7 macrophages polarized into M2a with IL-4/IL-13 and into M2c with IL-10 to 
clear fluorescently marked Neuro-2a malignant cells. Calreticulin (CRT) is one of the 
cellular signals, exposed on the surface of malignant cells, that play vital roles in 
controlling the phagocytosis process mediate by phagocytes including macrophages. 
Treatment of M2a (IL-4/IL-13) and M2c macrophages with SOCS1 peptide mimetics 
had no significant effects on M2a and M2c-mediated phagocytosis of CFSE-stained 
N2a cells compared with M2a (IL-4/IL-13) and M2c cells without SOCS1 peptide 
mimetic treatment, while it slightly increased the M2a (IL-4/IL-13), but not M2c, 
macrophage-mediated  phagocytosis of N2a cells that had their calreticulin receptors 
blocked. When N2a cells were blocked with anti-CRT antibody, M2a and M2c-
mediated phagocytosis was decreased. Interestingly, treatment of M2c with SOCS3 
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peptide mimetics coincided with blockage of CRT signals on N2a cells caused a 
significant increase in the phagocytosis of N2a cells mediated by M2c polarized 
macrophages.  
These data help to get a deeper understanding of macrophage functions in 
cleaning the microenvironment from apoptotic and malignant cells and even wound 
healing. Overall, this study sheds more light on how SOCS1/ SOCS3 can be used 
along with manipulation of “eat-me” signals exposed on malignant and apoptotic cells 
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Capan’s studies (Thesis, Wright State University, 2017) examined the roles of 
suppressors of cytokine signaling SOCS1 and SOCS3 peptide mimetics on the 
phagocytosis of fluorescently labeled malignant neuroblastoma target cell (Neuro-2a) 
by RAW264.7 murine macrophages.   The prominent “eat me” signal found in 
neuroblastoma cells is calreticulin (CRT), which permits macrophages to recognize 
and then phagocytize the malignant cells when M1 (pro-inflammatory) polarized 
RAW 264.7 macrophages were treated with SOCS1 peptide mimetic. An increase in 
phagocytosis was observed, but SOCS3 peptide mimetic had no effect on 
phagocytosis. Neither SOCS1 nor SOCS3 peptide mimetics showed a significant 
effect on the phagocytic ability of the IL-10-polaraized M2c (anti-inflammatory) 
macrophages when target cells were stained with carboxyfluorescein succinimidyl 
ester (CFSE). When target cells were treated with anti-CRT, phagocytosis was 
decreased by both M1 and M2c polarized macrophages. When M2 macrophages were 
treated with SOCS3 peptide mimetic and target cells were blocked with anti-CRT, 
which initiates apoptosis, an increase in phagocytosis was observed when compared 
to unblocked target cells.  
The present study is a continuation of Capan’s study in which SOCS1 and 
SOCS3 peptide mimetics were examined to determine if they had a similar effect on 
M2a macrophages polarized with either IL-4 or IL-13.  M1 macrophages are 
considered as inflammatory phagocytes involved in the phagocytosis of bacteria or 
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foreign particles, while M2 macrophages are considered to be anti-phagocytic and 























1.1 Macrophage polarization and functions   
Macrophages are essential phagocytic cells involved in both innate and adaptive 
immune systems and play vital roles in the host defense and inflammation such as 
clearance of cellular debris formed during tissue remodeling and removal of apoptotic 
cells (Mosser and Edwards, 2008). Macrophages are found almost in all tissues, and 
they arise from peripheral-blood mononuclear cells (PBMcs), which originate from 
myeloid progenitor cell in the bone marrow (Mosser and Edwards, 2008). Recent 
studies have reported that tissue- resident macrophages in the embryo are derived 
from yolk sac and fetal live precursors and then developed into resident state 
throughout adulthood (Gordon and Plüddemann, 2018). Under steady state or in 
response to inflammation, monocytes translocate from blood into tissues to restore the 
tissue-specific macrophages of the bone (osteoclasts), alveoli, central nervous system 
(microglial cells), connective tissue (histiocytes), gastrointestinal tract, liver (Kupffer 
cells), spleen and peritoneum (Mosser and Edwards, 2008). Macrophages have 
extraordinary plasticity; thus, they efficiently respond to signals within their 
environment and adjust their phenotype (Mosser and Edwards, 2008). Both innate and 
adaptive immune systems can strongly alter the macrophage physiology in a way that 
make the macrophages more sensitive to pathogens and inflammation and limit 
macrophage- mediated production of cytokines that could harm the immune system 
(Mosser and Edwards, 2008). Macrophages can be polarized into classical (M1) or 
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alternative (M2) macrophages, which are mirroring the T helper cells (Th1 and Th2) 
polarization, respectively (Wang et al. 2014). Macrophages can be polarized into M1 
phenotype by exposure to lipopolysaccharide (LPS)  and interferon- γ (IFN-γ) or 
tumor necrosis factor (TNF), or can be polarized into M2 macrophages, which are 
further classified into three subsets; M2a, activated by exposure to IL-4 or IL-13; 
M2b, activated by immune complexes (IC) and toll-like receptors (TLRs) or IL-1R 
agonists; and M2c, activated by IL-10 and glucocorticoid hormones (Mantovani et al. 
2002; Oishi et al. 2016). The hallmarks of M1 phenotype are high expression of pro-
inflammatory cytokines including IL-12, IL-23, and tumor necrosis factor-α (TNF-α) 
as well as production of ROSs and high nitric oxide (NO) (Oishi et al. 2016). 
However, M2 phenotype is characterized by production of IL-10 and IL-1 receptor 
antagonist (IL-1Ra) as well as high expression of scavenger, mannose and galactose 
receptors (Oishi et al. 2016). In addition, M1 cells are known to have antibacterial and 
anti-tumor effects as they release cytokines that suppress the nearby cells proliferation 
and destroy the contiguous tissue, while M2a and M2b function as immunoregulators 
and drive M2 phenotype responses through releasing cytokines that enhance the 
contiguous cell proliferation, and M2c macrophages are involved in 
immunosuppression and tissue remodeling (Mantovani et al. 2002).  The imbalanced 
dynamic changes of M1-M2 macrophage polarization is related to multiple diseases 
or inflammatory responses; M1 macrophages are associated with enhancing and 
preserving inflammation, while M2 macrophages are implicated in persistence of 
chronic inflammation (Wang et al. 2014). Different factors collaborate to regulate the 
macrophage polarization involving inflammatory modulators, signaling molecules, 
and transcription factors. In particular, Th1and Th2 cells play roles in driving 
macrophage polarization depending on interferon-responsive factor (IRF) and signal 
5 
 
transducers and activators of transcription (STATs) signaling pathways (Wang et al. 
2014). The M1 macrophage phenotype is activated by the IRF/STAT1 signaling 
pathway mediated by IFN- γ and TLR, while the M2 phenotype is activated by the 
activation of IRF/STAT6 pathway mediated by IL-4 and IL-13 (Wang et al. 2014). 
Thus, it is vital to identify the molecules involved in macrophage polarization and 
their interactions, which could help in understanding the diseases progression and 
finding new macrophage-dependent therapeutic strategies. 
1.2 Controlling the macrophage phagocytosis  
Macrophages are the professional phagocytes of immune system. In particular, 
they have a remarkably high capacity to clear unnecessary cellular materials in 
interstitial environment through a process called “phagocytosis” (Savill, 1997). 
Phagocytes are able to recognize and ingest all membrane-attached products resulting 
from apoptosis (i.e., programmed cell death of cells) and apoptotic bodies released 
from dying cells (Savill, 1997). The ability of phagocytes to speedily and efficiently 
clear the apoptotic cells helps to minimize tissue injury that could be caused by 
harmful materials released from dying cells and also protects the immune system from 
destructive auto-immune responses to apoptotic cell antigens (Savill, 1997). The 
uptake of viable or apoptotic cells is dependent on the existence of “eat-me” and/ or 
lack of “don’t-eat-me” signals (Gordon and Plüddemann, 2018). The cellular surfaces 
of apoptotic cells are different from viable cells as the cells undergoing apoptosis 
express particular markers of disposal including “eat-me” signals that are developed 
after multiple modifications in the plasma membrane elements, such as carbohydrate 
changes, exposure of phosphatidylserine (PS), existence of anionic thrombospondin 
1(TSP1) binding sites (Savill, 1997). Phagocytes employ various classes of receptors 
to initiate phagocytosis of apoptotic cells and even cancer cells, including phagocyte 
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lectins, phosphatidylserine receptors (PSRs), thrombospondin receptors, CD36 and 
the ανβ3integrin, macrophage 61D3 antigen, scavenger receptors, and ATP-binding 
cassette superfamily of membrane transporters (Savill, 1997).  
Calreticulin (CRT) is one of the cellular signals that play vital roles in controlling 
the phagocytosis process. This signal has been at the forefront of medical research 
into prediction of cancer condition and it has been investigated towards advancing 
fundamental knowledge of its characteristics and functions and its contribution to 
controlling tumor progression (Raghavan et al. 2013). CRT is defined as an 
endoplasmic reticulum- resident chaperon. CRT is constantly exposed on the cancer 
cell surface, when stimulated during the early phase of apoptosis by apoptotic stimuli, 
such as UV irradiation and anthracycline. CRT acts as “eat-me” signal that attracts 
macrophages and promotes the phagocytosis of the cells it is expressed on (Chao et. 
al., 2012; Martins et al. 2014; Fricker et al. 2012). Another signal that is defined to 
have inhibitory effects on the immune system during tumor growth is cluster of 
differentiation (CD47), which is a receptor expressed on the surface of some cells and 
works as anti-phagocytic “don’t-eat me” signal that inhibits the phagocytosis of 
apoptotic cells (Chao et. al., 2012). The tumor cells can escape the immune system 
through up-regulating the expression of CD47 to neutralize CRT signal resulting in 
continuing cancer growth (Chao et. al., 2012). CRT and CD47 along with 
phosphatidylserine (PS), another “eat-me” signal, work together to clear tumors and 
other pathogens from cellular microenvironment (Raghavan et al. 2013). It has been 
shown that CRT and CD47 are both expressed on living cells, but CD47 is expressed 
at a higher rate leading to offset the CRT signal (Raghavan et. al., 2013). However, 
CRT is predominantly expressed in neuroblastoma patients (Hsu et. al., 2004). In 
steady state, CRT and PS are expressed at the same levels on the surface of cells 
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undergoing programmed cell death. However, blocking or manipulating one of these 
signals will result in up-regulating the expression the other signal to make it detectible 
and phagocytosed by phagocytic cells (Krysko and Vandenabeele, 2008). Currently, 
the modulation of these signals expressed on cancer cells is under investigation and is 
advancing approach to increase the tumor clearance rate. 
1.3 Suppressors of cytokine signaling (SOCSs)  
Cytokines are substances secreted by particular types of immune cells and 
they are well known to be involved in the pathophysiology of different diseases, 
including their functions as modulators of the proliferation and differentiation of 
multiple types of cells including macrophages (Zhou et al. 2017). These suppressors 
of cytokine signaling (SOCS) cascades are activated as a result of stimulated 
interaction of cytokines with their corresponding cellular receptors, which in turn 
leads to stimulation of intracellular molecules, such as Janus kinases (JAKs) and 
STATs (Zhou et al. 2017). Macrophages are defined as target cells of certain 
cytokines and thus may be involved in many diseases’ pathogenesis. Cytokines and 
intracellular signaling cascades stimulate the polarization of macrophages into M1or 
M2 phenotypes in response to invading pathogens, injuries, or cancer onset (Zhou et 
al. 2017). Suppressors of cytokine signaling (SOCS) are a group of intracellular 
proteins that downregulate the cytokine signals through a negative feedback loop 
(Zhou et al. 2017). There are eight classes of SOCS family: SOCS1 to SOCS7 and 
cytokine-inducible Src homology 2 (SH2)-containing protein (CIS) (Zhou et al. 
2017). Recently, SOCS proteins have been identified to function as a molecular 
switch that regulates the immune initiation and inhibition as well as the polarization 
of macrophages into M1or M2 phenotypes (Zhou et al. 2017). SOCS1 and SOCS 3 
are the most widely identified members of SOCS family to have crucial roles in 
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directing M1 and M2 macrophage polarization (Wilson, 2014). Thus, these molecules 
are at the forefront of research into investigation new macrophage-based therapeutic 
strategies. JAK-STAT pathway is the most studied signaling cascade that is regulated 
by SOCS1 and SOCS3 (Wilson, 2014). Upon cytokines activation, the JAK-STAT 
pathway is stimulated leading to induction of SOCS1and SOCS3. SOCS1and SOCS3 
can down-regulate the cytokine signaling cascade by different ways: SOCS1directly 
binds to key phosphorylated tyrosine residues on JAK and blocks the catalytic 
function, while SOCS3 inhibits the JAK function by binding to the JAK-proximal 







 SOCS1expression is activated and can block the signaling pathway in the 
presence of growth hormones (GH), interferons, IL-4, IL-6, thrombopoietin (TPO), 
and prolactin (PRL) (Kile and Alexander, 2001).  SOCS1 regulates M1 phenotype by 
Figure1: JAK-STAT signaling pathway. The cytokine binds to its specific receptor and 
activates the STAT molecules.  The activated STAT molecules bind to DNA and initiate 
the expression of SOCS1 or SOCS3 proteins, which in turn suppress the cytokine 




inhibiting the INF-γ -induced JAK2/STAT1 pathway and toll like receptor (TLR) / 
nuclear factor kappa-light-chain-enhancer of activated B cells (NF-kB) signaling 
pathway through penetration of the stimulation loop of JAKs using its kinase 
inhibitory region (KIR) domain. This downregulation is correlated with attenuated 
LPS, IL-4, and INF-γ in some diseases (Zhou et al. 2017). SOCS1 not only regulates 
the M1 phenotype, but it can also regulate the M2 macrophage polarization (Wilson, 
2014). SOCS1 expression is strongly increased with M2 macrophage polarization and 
it plays important roles in driving the M2 functional features including a high arginase 
I (Arg-I) with a low inducible nitric oxide synthase (iNOS) expression (Wilson, 
2014). It has been clarified that a higher SOCS1/SOCS3 ratio is a potential marker for 
M2 phenotype, while a higher SOCS3/ SOCS1 ratio is associated with the expression 
of the M1 phenotype (Wilson, 2014). Recent studies have confirmed that SOCS-
1gene is vital for living after birth. Mice with deleted SOCS-1 gene were born with 
obvious normal health, but after 10 days, those mice were remarkably smaller than 
wild-type mice, failed to survive, and passed away within 3 weeks (Naka et al. 1998; 
Starr et al. 1998; Zhou et al. 2017). 
1.5 SOCS3  
SOCS3 is generally known to function as an inhibitor of STAT3, which is the 
fundamental regulatory molecule of immune homeostasis and disease pathogenesis. 
SOCS3 can be induced by various cytokines and growth hormones including IL-1β, 
IL-2, IL-4, and macrophage colony-stimulating factor (M-CSF) (Zhou et al. 2017). 
SOCS3 protein plays an important role in macrophage-mediated phagocytosis as it is 
able to repress the pro-inflammatory M1phenotype, which in turn inhibits the 
macrophage inflammatory responses (Qin et al. 2012). Recent studies investigated the 
effects of SOCS3 on the inflammatory properties by knocking out the SOCS3 gene 
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(Qin et al. 2012). SOCS3-deficient macrophage exhibited greater levels of pro-
inflammatory M1 phenotype markers, including IL-1β, IL-6, IL-12, IL-23, iNOS, 
CCL2, CXCL10, compared to wild type mice (Qin et al. 2012). In addition, SOCS3 
has been shown to have a regulatory effect on another molecule called “Mer receptor 
tyrosine kinase (MerTK)”, an intracellular regulator that inhibits the inflammatory 
responses mediated by the interactions between TLRs expressed on macrophages and 
DCs and pathogen-associated molecular patterns (PAMPS) exposed by attacking 
pathogens or even malignant cells, which in turn initiate the innate immune response 
(Zhang et al. 2016). Graham et al. (2006) suggest that the increased expression of 
MerTK on malignant cells penetrating macrophages might enhance the macrophage 
capability to clear apoptotic melanoma cells. Since the expression of MerTK on 
macrophages is associated with SOCS3 expression, the treatment of macrophages 
with SOCS3 could increase the expression of MerTK on macrophages, which 
consequently could enhance the macrophage phagocytosis (Zhang et al. 2016). 
             The current study focuses on the sophisticated roles of SOCS1 andSOCS3 
peptide mimetics on the inflammatory characteristics of RAW 264.7 murine 
macrophages. The primary inflammatory response of macrophage is detecting, 
engulfing and killing pathogens and apoptotic cells through phagocytosis process 
mediated by M2a and M2c Macrophage. SOCS proteins are strong regulators of target 
cell phagocytosis as they can repress particular intracellular signaling pathways and 







The hypothesis of this study is that anti-inflammatory M2a macrophages 
treated with SOCS1 protein will not display elevated phagocytosis of the neuro-2a 
cells while IL-4 or IL-13 polarized macrophages treated with SOCS3 peptide mimetic 
will show enhanced increases in the percentage of neuro-2a cells phagocytosed. These 
increases may be less than that induced by IL-10 polarized cells treated with SOCS3 
peptide mimetic because IL-10 is an autocrine for M2c cells. If this hypothesis is 
shown to be correct, both M2a and M2c macrophages induce apoptosis of malignant 











MATERIALS AND METHODS 
2.1 Cell lines 
           RAW 264.7 murine macrophage cell line (ATCC TIB-71) is an Abelson 
leukaemia virus transformed cell line. RAW264.7 cells are adherent and macrophage-
like cells obtained from adult male BALB/c mice. RAW264.7 macrophage-like were 
grown in 25 cm2 or 75cm2 vented cap cell culture flasks and incubated at 5% CO2 
with a temperature of 37°C using a water jacketed incubator. Cells were cultured in 
media contained Dulbecco’s Modified Eagle's Medium (DMEM) and 10% fetal 
bovine serum (FBS). Cell subcultures were done in vented cap flasks at a ratio of 1:5 
until reaching 70% confluency 
          The Neuro-2a murine neuroblast cell line (ATCC-CCL-131) is an adherent 
neuroblastoma cell line produced in a strain A mouse. Cells were cultured in 75 cm2 
vented cap flasks at 37°C and 5% CO2 in a water jacket incubator. Cells were cultured 
in a media containing Eagle's Medium (DMEM) and 10% fetal bovine serum (FBS). 
Cell subcultures were completed in vented cap flasks at a ratio of 1:10 until reaching 
80-90 % confluency. Eagle's Medium (DMEM), fetal bovine serum (FBS), and vented 
cap flasks were purchased from ThermoFisher Scientific. 
2.2 Polarization treatment 
          RAW 264.7 macrophages were grown in 75 cm2 vented cap flasks until 
reaching a confluency of 70%. Cells then were removed from the flasks by using a 
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cell scraper. The cell suspension was transferred into 15 ml conical tubes. Cells were 
centrifuged at 1700 revolutions per minute (4°C) for 5 minutes. Supernatants were 
removed using vacuum flask, while cell pellets were re-suspended in 1ml of complete 
growth medium. Cells were counted and aliquoted into 25 cm2 culture flasks 
containing 10% growth media and polarization treatment at seeding density of 1-
2×106 cells per flask. Cells were allowed to become adherent to flasks for 18 hours. 
RAW 264.7 cells were treated with IL-4 and IL-13 to reach M2a phenotype with and 
without SOCS1/3 and treated with IL-13 to reach M2c phenotype with and without 
SOCS1/3. IL-4, IL-13, and IL-10 were used at concentration of 20 ng/mL (Biolegend) 
and SOCS1/3 were used at concentration of 35 μM (Genscript). Cells were then 
prepared for phagocytosis assay. 
2.3 CFSE staining of Neuro-2a Cells 
         Neuro-2a cells were harvested from culture flasks upon reaching 80-90% 
confluency by using trypsin. Cells were counted on hemocytometer, and 3×106 cells 
were aliquoted into each 15 mL conical tube. Cells were then re-suspended in 
Phosphate-buffered saline (PBS) containing 0.5 μM of staining solution (1 mL the 
final volume), and then cells were incubated at room temperature (RT) for 20 
minutes. Cells were then washed with 10% complete growth medium and centrifuged 
at 1700 revolutions per minute (rpm) for 5 minutes at 4°C. Finally, cells were re-
suspended in 1 mL of 10% growth media and added to the polarized macrophages at 
2:1 ratio. 
2.4 Phagocytosis assay 
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CFSE-stained N2a cells or anti-CRT blocked N2a cells were added into flasks 
of polarized macrophages at a ratio of 2:1 with 4 mL new 10% of growth media. Cells 
were then incubated with macrophages for one hour at 37°C and 5% CO2 to allow the 
phagocytosis process to occur. Cells were then washed five times with 1X cold PBS 
to stop the uptake of N2a cells. Cells then were scrapped with final PBS wash and 
added to 15 mL conical tube and prepared for cell surface antigen staining of 
macrophages to be detected by flow cytometry.  
2.5 Flow cytometry 
Cell surface antigen staining 
          After the phagocytosis assay, the cells were collected, centrifuged, supernatant 
was removed, and cell pellet was re-suspended with 500 μL of 1% Bovine Serum 
Albumin (BSA) and transferred into micro-centrifuge tube. Cells were centrifuged, 
supernatant was removed, and then cells were treated with 500 μL of 3% BSA to 
prepare for the antibody staining. Then, cells were washed with 500 μL of 1% BSA, 
centrifuged, and supernatant was removed. Cells were stained with an appropriate 
amount of F4/80 primary antibody conjugated with eFluor 660 (ebioscience) and 
antibody staining solution (ASS) at 100 μL final volume and incubated for 30 minutes 
at RT in dark. Cells were then washed with 300 μL of 1% BSA. Finally, cells were re-
suspended with 500 μL of cold PBS and filtered through Falcon tubes and analyzed 
by flow cytometry on an Accuri C6 Flow Cytometer (BD Biosciences).    
 Intracellular staining 
          Neuro 2a cells were grown until reached 80-90% confluency. Cells were 
harvested from the flask using trypsin and re-suspended in 1X PBS. Cells were then 
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counted on hemocytometer and 3×106 cells per tube were placed into micro-
centrifuge tubes with PBS at 500 μL final volume. Cells were centrifuged at 1200 rpm 
for 5 minutes at 4°C and the supernatants were removed. Cells were then re-
suspended with 500 μL of fixation buffer (Biolegend) for 20 minutes in the dark at 
RT. Cells were centrifuged and the supernatants were removed. Cells were washed 
twice with 500 μL of 1X permeabilization buffer (Biolegend). After centrifuging and 
removing supernatants, cells were stained for Calreticulin (CRT) with an appropriate 
amount of anti-CRT antibody conjugated with Alexa Fluro 488 (Abcam) and 
incubated at RT for 30 minutes in the dark. Cells were then washed with 500 μL of 
permeabilization buffer. Finally, cells were re-suspended in 1 mL of fresh 10% 
growth media and added on top of RAW cells with 4 mL fresh 10% media to undergo 
phagocytosis assay and then analyzed by flow cytometry on an Accuri C6 Flow 
Cytometer (BD Biosciences).    
 
Table 1: List of antibodies and isotypes and their concentrations used in flow 
cytometry analysis 
 
Antibody Concentration Company 
Anti-F4/80 conjugated to eFluro 660 10 µg/mL  ThermoFisher 
Rat IgG2a K Isotype Control conjugated 
to eFluro 660 




2.6 Statistical Significance   
  Statistical significance was calculated using One-Way ANOVA - SigmaPlot 











Anti-Calreticulin conjugated to Alexa 
Fluro 488 
10 µg/mL ThermoFisher 
Rabbit IgG Isotype Control conjugated to 
Alexa Fluro 488 




M2a (both treated by IL-4/IL-13) and M2c displayed similar abilities to clear the 
malignant cells 
 Following 18-hour treatment with IL-4/IL-13 for M2a and with IL-10 for M2c 
phenotype, M2a (both polarized with IL-4/IL-13) and M2c macrophages showed 
similar amount of phagocytosis of CFSE-stained N2a cells (Fig. 2-7).  
 
M2a (polarized with I-4/IL-13) and M2c-mediated phagocytosis of N2a cells is 
decreased when Calreticulin receptor, the “eat-me” signal is blocked 
 When calreticulin (CRT) receptors on neuro (N2a) cells are blocked, the amount 
of phagocytosed N2a cells is significantly decreased in M2a (both polarized with IL-
4/IL-13) and M2c macrophages compared to M2a and M2c cells co-cultured with 
unblocked N2a cells. (Fig.9 -12). 
SOCS1 peptide mimetic has no significant effects on phagocytosis ability of M2a 
and M2c macrophages 
SOCS1 peptide mimetic does not significantly affect the M2a (IL-4/IL-13) and 
M2c cells-mediated phagocytosis of CFSE-stained N2a cells compared with M2a and 
M2c cells without SOCS1 peptide mimetic treatment (Fig. 2– 7), while it slightly 
increases the M2a (IL-4/IL-13), but not M2c, macrophage-mediated  phagocytosis of 
N2a cells that had their calreticulin (CRT) receptors blocked (Fig. 9-13). 
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SOCS3 peptide mimetic significantly increases the phagocytosis rate of M2c 
macrophages, but not M2a macrophages  
 M2a (IL-4/IL-13) macrophages treated with SOCS3 peptide mimetics display 
no significant increases in their phagocytosis of either CFSE-stained N2a cells or N2a 
cells blocked with anti-CRT antibody (Fig.9-14). However, M2c macrophages treated 
with SOCS3 peptide mimetics show a significant increase in their phagocytosis of 












Figure 2: Phagocytosis of CFSE-stained Neuro-2a (N2a) cells by RAW264.7 
Macrophages polarized with IL-4 into M2a macrophages with SOCS1/SOCS3. M2a 
cells treated with SOCS1 and SOCS3 phagocytose similar amount of CFSE-stained 
N2a cells compared with M2a cells without SOCS1/SOCS3. There was no significant 







Figure 3: Quadrant graphs represent the phagocytosis rate of RAW264.7 
macrophages polarized into M2a (IL-4) phenotype. M2a cells treated with either 
SOCS1 (B) or SOCS3 (C) phagocytosed higher but not significant amount of CFSE-
stained N2a cells compared with M2a Cells not treated with SOCS1/3 (A) there was 
no significant difference in the phagocytic ability between SOCS1-treated M2a cells 
(B) and SOCS3-treated M2a cells (C). Quadrants were represented compared to 
unstained M0 macrophages (D). Experiments were completed in triplicates with one 






Figure 4: Phagocytosis of CFSE-stained Neuro-2a (N2a) cells by RAW264.7 
Macrophages polarized with IL-13 into M2a macrophages with SOCS1/SOCS3. M2a 
cells treated with SOCS1 phagocytose similar amount of CFSE-stained N2a cells 
compared with M2a cells without SOCS1/SOCS3. M2a macrophages treated with 
SOCS3 show a slight increase in their phagocytic ability compared with M2a cells 
without SOCS1/3. There was no significant statistical difference in the phagocytosis 


























Figure 5: Quadrant graphs represent the phagocytosis rate of RAW264.7 
macrophages polarized into M2a (IL-13) phenotype. M2a cells treated with either 
SOCS1 (B) or SOCS3 (C) phagocytosed higher amount of CFSE-stained N2a cells 
compared with M2a Cells not treated with SOCS1/3 (A) but not statistically 
significant. There was no significant difference in the phagocytic ability between 
SOCS1-treated M2a cells (B) and SOCS3-treated M2a cells (C). Quadrants were 
represented compared to unstained M0 macrophages (D). Experiments were 





Figure 6: Phagocytosis of CFSE-stained Neuro-2a (N2a) cells by RAW264.7 
Macrophages polarized with IL-10 into M2c macrophages with SOCS1/SOCS3. M2c 
cells treated with either SOCS1 or SOCS3 peptide mimetics phagocytosed similar 
amount of CFSE-stained N2a cells compared to M2c cells without SOCS1/SOCS3. 
There were no significant statistical differences in the phagocytosis rate of M2a cells 
























Figure 7: Quadrant graphs represent the phagocytosis rate of RAW264.7 
macrophages polarized into M2c (IL-10) phenotype. M2c cells treated with either 
SOCS1(B) or SOCS3 (C) peptide mimetics phagocytosed similar amount of CFSE-
stained N2a cells compared with M2c cells not treated with SOCS1/3 (A) and. There 
were no significant statistical differences in the phagocytic ability among SOCS1-
treated M2c cells, SOCS3-treated M2c, and M2c cells without SOCS1/3. Quadrants 
were represented compared to unstained M0 macrophages (D). Experiments were 
























Figure 8: The effects of anti-CRT antibody on the phagocytic abilities of M2a and 
M2c polarized RAW264.7 macrophages. Blockage of calreticulin receptors on N2a 
cells significantly decreased the phagocytosis rate of N2a cells, showing higher 
survival rates of N2a cells. All M2a and M2c polarized macrophages displayed 
reduced phagocytic activates when co-cultured with N2a cells that had their 






Comparison of M2a and M2c macrophage phagocytosis before 
and after blocking the calreticulin (CRT) receptors on N2a cells 
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Figure 9: M2a (IL-4) polarized macrophages-mediated phagocytosis of N2a cells 
blocked with anti-CRT antibody before and after treatment with SOCS1/SOCS3. M2a 
cells treated with SOCS1 showed a non-significant increase in the phagocytosis rate 
compared to M2a cells not treated with SOCS1/3 and M2a macrophages treated with 
SOCS3. There were no observed differences in the phagocytic abilities between 





Figure 10: M2a (IL-13) polarized macrophages-mediated phagocytosis of N2a cells 
blocked with anti-CRT antibody before and after treatment with SOCS1/SOCS3. M2a 
cells treated with SOCS1 displayed non-significant higher phagocytosis rate 
compared to M2a cells without SOCS1/3 and M2a macrophages treated with SOCS3. 
There were no observed differences in the phagocytic abilities between SOCS3-





















Figure 11: M2c (IL-10) polarized macrophages-mediated phagocytosis of N2a cells 
blocked with anti-CRT antibody before and after treatment with SOCS1/SOCS3. M2c 
cells treated with either SOCS3 displayed a significant increase in their phagocytosis 

































Figure 12: Quadrant graphs represent the RAW264.7 macrophages phagocytosis rate 
of Anti-CRT Neuro-2a (N2a) cells. M2a (IL-4) polarized macrophages (A), M2a (IL-
13) polarized macrophages (B) and M2c (IL-10) polarized macrophages (C) displayed 
no significant differences in their phagocytosis of N2a cells that had their “eat-me” 
signal blocked with anti-CRT antibody. Quadrants were represented compared to 
unstained M0 macrophages (D). Experiments were completed in triplicates with one 

























Figure 13: Quadrant graphs represent the effect of SOCS1 peptide mimetics on 
RAW264.7 macrophages phagocytosis of Anti-CRT Neuro-2a (N2a) cells. M2a (IL-
4) polarized macrophages (A) and M2a (IL-13) polarized macrophages (B) 
phagocytosed more amount of anti-CRT-N2a cells than M2c (IL-10) polarized 
macrophages (C) but not statistically significant. There was no a significant difference 
in the phagocytosis rate of N2a cells between M2a (IL-4) (A) and M2a (IL-13) (B) 
polarized macrophages. Quadrants were represented compared to unstained M0 
























Figure 14: Quadrant graphs represent the effect of SOCS3 peptide mimetics on 
RAW264.7 macrophages phagocytosis of Anti-CRT Neuro-2a (N2a) cells. M2c (IL-
10) polarized macrophages (C) significantly phagocytosed more amount of anti-CRT-
N2a cells than M2a (IL-10) (A) and M2a (IL-13) (B) polarized macrophages. There 
was no a significant difference in the phagocytosis rate of N2a cells between M2a (IL-
4) (A) and M2a (IL-13) (B) polarized macrophages. Quadrants were represented 
compared to unstained M0 macrophages (D). Experiments were completed in 






Figure 15: The effects of SOCS1/3 peptide mimetics on M2a (IL-4) polarized 
RAW264.7 macrophage-mediated phagocytosis of either CFSE-stained or anti-CRT-
blocked N2a cells. Blockage of CRT receptors on N2a cells caused a decrease in the 
phagocytosis rate of M2a(IL-4) treated with SOCS1/SOCS3 and M2a macrophages 




















Figure 16: The effects of SOCS1/3 peptide mimetics on M2a (IL-13) polarized 
RAW264.7 macrophage-mediated phagocytosis of either CFSE-stained or anti-CRT-
blocked N2a cells. Blockage of CRT receptors on N2a cells caused a decrease in the 
phagocytosis rate of M2a(IL-13) treated with SOCS3 and M2a macrophages without 
SOCS peptide mimetic treatment, while it caused a slight increase in the phagocytosis 
























Figure 17: The effects of SOCS1/3 peptide mimetics on M2c (IL-10) polarized 
RAW264.7 macrophage-mediated phagocytosis of either CFSE-stained or anti-CRT-
blocked N2a cells .Blockage of CRT receptors on N2a cells caused a significant 
increase in the phagocytosis mediated by  M2c (IL-10) treated with SOCS3, while it 
decreased phagocytosis mediated by M2c(IL-10) treated with SOCS1 peptide 














 The current study aims to investigate whether treatment of anti-inflammatory 
M2a and M2c polarized macrophages with SOCS3 peptide mimetics could result in 
increased phagocytosis rate of malignant cells. Blockage of calreticulin (CRT) 
receptors, the “eat-me” signal that induce phagocytosis of malignant cells, should 
reduce the ability of RAW264.7 macrophages to phagocytose neuro-2a cells.  
 When CFSE-stained N2a cells were co-cultured with M2a and M2c polarized 
macrophages, M2a (both polarized with IL-4/IL-13) and M2c macrophages showed 
similar amount of phagocytosis of CFSE-stained N2a cells. M2a and M2c phagocytic 
abilities were also similar to the phagocytic ability of M0 unpolarized macrophages 
(data not shown) as investigated by Capan (2017). These data indicate that M2a and 
M2c polarized macrophages are regulatory effectors in the clearance of malignant 
cells. 
 Upon blockage of the “eat-me” signal, calreticulin (CRT) receptor, on the 
target N2a cells using anti-CRT antibody, the phagocytic abilities of M2a (both 
polarized with IL-4/IL-13) and M2c polarized macrophages were significantly 
decreased compared with the phagocytosis rates of M2a and M2c polarized 
macrophages co-cultured with CFSE-labeled N2a cells. This investigation indicates 
that calreticulin receptor is a crucial “eat-me” signal exposed on N2a cells and plays a 
key role in the clearance of malignant cells. 
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RAW264.7 macrophages polarized into M2a (with IL-4 or IL-13) and M2c 
(with IL-10) were treated with SOCS1/ SOCS3 peptide mimetics for 18 hours. The 
addition of SOCS1 peptide mimetic did not significantly affect the phagocytic ability 
of M2a macrophage polarized with either IL-4 or IL-13 and M2c macrophages. M2a 
(IL-4/IL-13) polarized macrophages treated with SOCS1 showed a non-significant 
slight increase in their phagocytosis of CFSE- stained N2a cells. These observations 
could be attributed to the upregulation of cytokines and receptors involved in M2a-
mediated phagocytosis without switching the anti-inflammatory phenotype into pro-
inflammatory phenotype.  Similarly, M2c treated with SOCS1 peptide mimetics 
displayed no difference in their phagocytic ability compared with M2c macrophages 
without SOCS1 treatment. 
 SOCS3 treatment had a positive impact on the phagocytic ability of 
RAW264.7 macrophages polarized into M2a and M2c phenotypes. The addition of 
SOCS3 peptide mimetics into M2a (IL-4 or IL-13) and M2c macrophages caused 
these polarized cells to phagocytose more target CFSE-stained N2a cells compared to 
M2a and M2c macrophages without SOCS3. Similar to SOCS1, this observation 
could be due to activation of particular cytokines and receptor expression that may be 
involved in phagocytic process. Interestingly, SOCS3 peptide mimetics-treatment of 
M2c polarized macrophages with blockage of calreticulin receptor, the “eat-me” 
signal, on N2a cells remarkably enhanced M2c polarized macrophages ability to 
phagocytose much more target anti-CRT-N2a cells. This result indicates that the 
increase in the SOCS3-treated M2c macrophage phagocytosis of anti-CRT- N2a cells 
is due to the blockage of calreticulin receptor before they are exposed on the surface 
of N2a cells, which in turn causes a disturbance in the cellular membrane 
composition. The absence of CRT results in up-regulating the expression of the other 
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phagocytic signal PS, which makes the malignant cells apoptotic and detectible by 
phagocytic SOCS3-treated M2c macrophages. Another clarification is that the 
enhanced increase in the SOCS3-treated M2c macrophages could be attributed to the 
up-regulated expression of tumor associated macrophage receptor merTK, an 
apoptotic intracellular inhibitor that down-regulates macrophage inflammatory 
responses in a negative feedback loop and play a key role in the apoptosis of 
malignant cells (Zizzo et al. 2012). Zhang et al., (2016) have found that merTK 
expression is up-regulated by SOCS3 peptide mimetics, and this increase in the 
expression of merTK leads to enhancing macrophage-mediated phagocytosis. 
  Overall, the current study illustrates that polarization of macrophages into 
different phenotypes with various functions play a key role in the regulation of 
inflammatory responses including phagocytosis of pathogens, apoptotic cells or 
malignant cells through activation or inhibition of cytokine signaling pathways. All 
the current results indicate that SOCS peptide mimetics are crucial effectors that can 
be used to enhance the phagocytic abilities of macrophages with particular 
phenotypes to efficiently clear malignancies. Treatment of M2a polarized 
macrophages with SOCS3 caused those macrophages to phagocytose more N2a cells 
through increasing cytokines involved in phagocytic process. Remarkably, treatment 
of M2c polarized macrophages with SOCS3 caused an enhanced increase in their 
phagocytosis of N2a cells that had their calreticulin receptors blocked. This result 
could be attributed to upregulation of the expression of PS signal or tumor associated 
macrophage receptor merTK, which make malignant cells become apoptotic cells and 






 The current study provides many various directions for future study 
depending on the protocol used in the present study. This study included 
RAW264.7 macrophages as phagocytes and Neuro-2a cells as target cells. The 
logical direction in the future is investigating the phagocytic abilities of other 
types of macrophages such as J774A.1 murine macrophage. Other target cells 
should be tested including cells obtained from other types of malignancies, 
including lung, brain, breast, and pancreatic cancers.  
In this study, RAW264.7 macrophages were polarized with IL-4 or IL-13 
into M2a phenotype and with IL-10 into M2c phenotype. SOCS3 peptide mimetic 
treatment of M2a and M2c characterized the phagocytic abilities of these 
phenotypes. Only M2c polarized macrophages showed an enhanced increase in 
their phagocytic ability when they co-cultured with Neuro-2a cells that had their 
calreticulin receptors blocked. To get more understanding of M2c phenotype 
characterization and its ability to clear malignant cells, macrophages should be 
polarized using glucocorticoid hormones as these hormones have been reported 
to be polarizing agents that drive M2c phenotype. 
Recent studies have shown that SOCS3-treatment of M2c polarized 
macrophages is associated with high expression of tumor associated macrophage 
receptor merTK. Thus, measuring the expression of merTK on M2c macrophages 
along with other macrophage phenotypes is another avenue that would be 
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beneficial to explore the molecular basis of this receptor and its contribution in 
the clearance of malignant cells. 
Polarization of macrophages switches them into various phenotypes with 
distinct properties and functions. Cytokine profile is one of the properties that is 
affected with polarization treatment of macrophages along with using SOCS 
peptide mimetics, which in turn lead to inhibition or activation of cytokines. Any 
alterations in the cytokine profiles could affect the whole microenvironment, 
including the immune cells and their capabilities to detect, respond and react 
with harmful foreign materials. Since SOCS3-treated M2c macrophages possess 
high ability to phagocytose malignant cells, their cytokines should be measured 
to understand their roles and contributions in clearance of pathogens, apoptotic 
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